Michel Nuta

Chief Medical Officer of Theraclion, maker of Sonovein®
Medical doctor, Chief Medical Officer of Theraclion since 2013. Over 30 years in medical devices, including 13 years at VNUS Medical Technologies.
Portrait de l'auteur

At a glance

  • Vice President Veins and Chief Medical Officer of Theraclion, which he joined in January 2013
  • Medical doctor
  • Over 30 years in medical devices
  • Former clinical researcher at VNUS Medical Technologies, a pioneer of endovenous radiofrequency ablation

The thread running through his career

One question has guided his career: how can varicose veins be treated in ever less invasive ways, while backing each step with solid clinical evidence? He has answered it twice.

1

Radiofrequency

At VNUS Medical Technologies, from 1999 to 2012, as a clinical researcher. He helped spread endovenous radiofrequency ablation, which replaced part of surgical procedures with a catheter-based treatment.

2

Ultrasound

At Theraclion since 2013, as Chief Medical Officer, in charge of clinical research and the development of a medical device. With high-intensity focused ultrasound (HIFU), treatment goes one step further: it works from outside the body, with no incision and no catheter. He bridges the technology and the daily practice of vascular physicians, and presents ultrasound-guided treatment of the superficial leg veins at medical congresses.

His conviction: an innovation is only worth something if physicians adopt it, and that takes rigorous clinical studies and close dialogue with practitioners. In 2017, he summed up his goal as offering “a new non-invasive option to the growing number of patients”.

Today, he wants HIFU treatment of varicose veins to be recognised by the vascular community, just as radiofrequency ablation was. To get there, he relies on solid clinical data in Europe and in the United States, where Theraclion is running the pivotal study on Sonovein®, and on a wider network of centres and practitioners trained in the technique. His aim has not changed: patients with venous insufficiency should be able to get treatment without an incision or a catheter.

Editorial scope

What he writes about here

He signs: the medical side of HIFU technology, medical topics explained for the general public, advice for patients, and his view on the potential of HIFU in medicine.
He does not sign: engineering, the business model or business ambitions.

Education

YearsInstitutionDegreeLocation
1992 to 1993ESCPMedical management and marketingParis, France

Career

YearsRoleCompany
Since 2013Chief Medical OfficerTheraclion
1999 to 2012Clinical researcherVNUS Medical Technologies

Publications and talks

  • Co-author of Role of Duplex Imaging in Endovenous Obliteration for Primary Venous Insufficiency (O. Pichot, C. Sessa, J. G. Chandler, M. Nuta, M. Perrin), Journal of Endovascular Therapy, 2000
  • Author of Intersections in the Vein Treatment World: Stripping, Catheters, and HIFU, Vein Magazine
  • Speaker: Ultrasound-guided HIFU treatment in superficial lower limb veins, a talk given in 2018 and available on YouTube

In the press